1. Home
  2. OCGN vs SVC Comparison

OCGN vs SVC Comparison

Compare OCGN & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • SVC
  • Stock Information
  • Founded
  • OCGN 2013
  • SVC 1995
  • Country
  • OCGN United States
  • SVC United States
  • Employees
  • OCGN N/A
  • SVC N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • SVC Real Estate Investment Trusts
  • Sector
  • OCGN Health Care
  • SVC Real Estate
  • Exchange
  • OCGN Nasdaq
  • SVC Nasdaq
  • Market Cap
  • OCGN 321.7M
  • SVC 380.4M
  • IPO Year
  • OCGN N/A
  • SVC N/A
  • Fundamental
  • Price
  • OCGN $1.19
  • SVC $1.74
  • Analyst Decision
  • OCGN Strong Buy
  • SVC Hold
  • Analyst Count
  • OCGN 2
  • SVC 2
  • Target Price
  • OCGN $7.00
  • SVC $2.75
  • AVG Volume (30 Days)
  • OCGN 3.2M
  • SVC 1.6M
  • Earning Date
  • OCGN 11-05-2025
  • SVC 11-05-2025
  • Dividend Yield
  • OCGN N/A
  • SVC 2.31%
  • EPS Growth
  • OCGN N/A
  • SVC N/A
  • EPS
  • OCGN N/A
  • SVC N/A
  • Revenue
  • OCGN $5,370,000.00
  • SVC $1,873,944,000.00
  • Revenue This Year
  • OCGN N/A
  • SVC N/A
  • Revenue Next Year
  • OCGN N/A
  • SVC N/A
  • P/E Ratio
  • OCGN N/A
  • SVC N/A
  • Revenue Growth
  • OCGN 14.26
  • SVC N/A
  • 52 Week Low
  • OCGN $0.52
  • SVC $1.55
  • 52 Week High
  • OCGN $1.90
  • SVC $3.08
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 36.58
  • SVC 38.07
  • Support Level
  • OCGN $1.14
  • SVC $1.55
  • Resistance Level
  • OCGN $1.22
  • SVC $1.71
  • Average True Range (ATR)
  • OCGN 0.08
  • SVC 0.10
  • MACD
  • OCGN -0.01
  • SVC 0.01
  • Stochastic Oscillator
  • OCGN 28.79
  • SVC 30.00

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

Share on Social Networks: